Fitness cost of chromosomal drug resistance-conferring mutations
about
Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant BacteriaThe fitness costs of antibiotic resistance mutationsA structural basis for the antibiotic resistance conferred by an A1408G mutation in 16S rRNA and for the antiprotozoal activity of aminoglycosidesImpact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosisAre survey-based estimates of the burden of drug resistant TB too low? Insight from a simulation studyDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentPre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitroMDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 YearsInfluence of antibiotic selection on genetic composition of Escherichia coli populations from conventional and organic dairy farms.Reversibility of antibiotic resistanceImpact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs.Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia.Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure.Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse.23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G.Phase variation of poly-N-acetylglucosamine expression in Staphylococcus aureus.Artificial gene amplification reveals an abundance of promiscuous resistance determinants in Escherichia coliFitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BCA suitable streptomycin-resistant mutant for constructing unmarked in-frame gene deletions using rpsL as a counter-selection marker.Dynamics of quinolone resistance in fecal Escherichia coli of finishing pigs after ciprofloxacin administration.Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis.Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessusFitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.Low fitness cost of the multidrug resistance gene cfr.Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes.Do tradeoffs structure antibiotic inhibition, resistance, and resource use among soil-borne Streptomyces?Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural hostPersistence of resistant Staphylococcus epidermidis after single course of clarithromycinEffect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis.In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis AntibioticsA fluoroquinolone resistance associated mutation in gyrA Affects DNA supercoiling in Campylobacter jejuniDynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients.Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2.Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control StudyDynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission.
P2860
Q26741585-65803D1D-4536-4239-9DFF-3F56287B1CF6Q26825334-1CA8DA10-79AD-4274-A030-ACDA4DFD954AQ27675767-FB366AB1-0CA3-4931-8129-8716830C7240Q28469011-09572A1F-DA7D-4808-8007-9D653890263EQ28472943-D3AA5BBE-7BD1-49A3-B017-0D3990E84BAFQ28478602-57AE5556-3000-4F33-BC96-71C902504249Q28478663-E7D4B66A-C673-41A0-A952-AF885374A43EQ28551671-6C508E6B-4B57-4941-B60C-D4C1EFBA8221Q30480620-142B4925-B5DE-4F28-BBBF-25F12082E3B2Q33667524-B942B689-6C7D-4944-B15A-E13C2FCB95F5Q33676306-3A874824-71FB-4BA9-9AA8-F3FF0E217486Q33703858-2FE6C92C-C8BA-4BFA-BDD6-4DFD76D5FF17Q33756688-BCE05F33-924C-4C44-A81C-31713293729EQ33863124-1B9E29E1-44D5-4275-976D-3E5AC3D0AD28Q33935053-8C795B36-55CC-4A00-8C51-4DB4F05DD1ECQ33982795-EBBA09BA-EFBC-4251-9814-B6019D65B770Q34025067-49F74B7D-DE4C-4C05-A924-8B6B4E45725AQ34123778-B2FF34FE-FA28-404E-906E-EE11D92E3398Q34277414-CF742BF6-9763-4E4A-932E-BEBA055E64AEQ34339497-D645A20C-99FE-4F18-9E67-77C633CC8478Q34631045-FA842DC9-6236-4E0F-B951-672600AAEB38Q34974987-0A8BA360-B441-4A47-B7AD-FC834868235FQ34999398-52C01002-489A-41DE-BB85-E4A33F1E97F8Q35065085-2E78A4C6-EC8D-4D14-8AFA-1951CD1657AAQ35096921-2B7636A6-5191-424A-8F41-C8BD49172BC7Q35107675-01093608-66EA-43B5-851D-8CFCD4591547Q35139469-115C98AB-01C7-4381-BE32-17957598AAE1Q35635595-8BD1ED0C-1D97-4241-AD80-88C70FAB0481Q35775410-D17711D7-138F-4420-A229-CB360EAE9097Q35806422-20D040AA-314A-4386-B3BA-0517E8E47AA1Q35847429-03C2E154-CAEF-4CBC-A1C4-0B3769EE7940Q36018737-BC47A045-452F-4A14-A3F2-44A5E14CDE50Q36056408-5E6843FA-A7B6-4C1D-B855-F259BBDC5D26Q36159080-0E6BDA8A-7436-42B6-9AA9-C09586CCA013Q36208337-6048DDE2-4B51-41C8-8150-F41CBD71FF2AQ36290567-75ADC2DD-8C3F-4208-AE5C-800E892CE8D7Q36313199-5763EDCE-BD0F-4C64-AEB7-3B989DB48E97Q36365273-E3BFDB4B-5899-457A-A0F9-E58EC4E7D27EQ36368678-F1C3D58A-0A98-4256-8AA3-CE2E17917CD0Q36558393-A69F20BC-959C-4C6A-8B0B-647F2B5BF551
P2860
Fitness cost of chromosomal drug resistance-conferring mutations
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fitness cost of chromosomal drug resistance-conferring mutations
@ast
Fitness cost of chromosomal drug resistance-conferring mutations
@en
Fitness cost of chromosomal drug resistance-conferring mutations
@nl
type
label
Fitness cost of chromosomal drug resistance-conferring mutations
@ast
Fitness cost of chromosomal drug resistance-conferring mutations
@en
Fitness cost of chromosomal drug resistance-conferring mutations
@nl
prefLabel
Fitness cost of chromosomal drug resistance-conferring mutations
@ast
Fitness cost of chromosomal drug resistance-conferring mutations
@en
Fitness cost of chromosomal drug resistance-conferring mutations
@nl
P2093
P2860
P1476
Fitness cost of chromosomal drug resistance-conferring mutations
@en
P2093
Antje Sturmfels
Burkhard Springer
Martin Kappler
Michel Pletschette
Therdsak Prammananan
P2860
P304
P356
10.1128/AAC.46.5.1204-1211.2002
P407
P577
2002-05-01T00:00:00Z